Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to -$0.06.

  • Lifecore Biomedical, Inc. \De\'s EPS (Basic) rose 7550.42% to -$0.06 in Q2 2025 from the same period last year, while for May 2025 it was -$1.27, marking a year-over-year decrease of 48605.81%. This contributed to the annual value of -$1.27 for FY2025, which is 42666.46% down from last year.
  • Latest data reveals that Lifecore Biomedical, Inc. \De\ reported EPS (Basic) of -$0.06 as of Q2 2025, which was up 7550.42% from -$0.47 recorded in Q1 2025.
  • Lifecore Biomedical, Inc. \De\'s 5-year EPS (Basic) high stood at $0.51 for Q1 2024, and its period low was -$1.75 during Q2 2022.
  • Its 5-year average for EPS (Basic) is -$0.4, with a median of -$0.34 in 2021.
  • As far as peak fluctuations go, Lifecore Biomedical, Inc. \De\'s EPS (Basic) tumbled by 236232.9% in 2022, and later surged by 20930.23% in 2023.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s EPS (Basic) (Quarter) stood at -$1.31 in 2021, then skyrocketed by 67.18% to -$0.43 in 2022, then surged by 209.3% to $0.47 in 2023, then crashed by 153.19% to -$0.25 in 2024, then surged by 76.48% to -$0.06 in 2025.
  • Its EPS (Basic) stands at -$0.06 for Q2 2025, versus -$0.47 for Q1 2025 and -$0.25 for Q4 2024.